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Dr Hazim J. Safi (Houston, Tex). I thank Adam Beck, MD,
for sending me this manuscript well in advance. The authors
have developed a prediction model for 30-day and 1-year mor-
tality after thoracic endovascular aortic repair (TEVAR). It is an
important contribution to our vascular literature. Most sur-
geons make this assessment (implicitly) when deciding on how
to manage patients with aneurysms. I congratulate the authors
for quantifying the relationship between the risk factors and
mortality rate. However, I wish that the authors had conduc-
ted an analysis to evaluate the effect of known statin use on
the hazard ratio. This might provide some assistance in inter-
preting the otherwise paradoxical findings. I have three ques-
tions:
1. Why didn’t the authors use the effective glomerular filtration. Can the authors elaborate on the incidence of neurological
deficit, stroke, paraplegia or paraparesis, and its impact on
mortality rate?
. Can the authors establish the need for adjunct procedures
preoperatively?
I thank the authors for their beautifully written manuscript
nd advances in our understanding of the risk factors that are
resent in TEVAR.
Dr Adam W. Beck. Thank you, Dr Safi. With regard to your
rst question regarding using the estimated glomerular filtration
ate (eGFR) rather than creatinine, we have preoperative creatinine
n our database, so that was the value that we used for the analysis.
owever, I do agree that eGFR would be a more accurate descrip-
ion of the patients’ renal function. We used a fairly strict definition
or renal insufficiency, with a creatinine of1.8, and perhaps using
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1-year mortality.
In terms of the neurological complications of TEVAR and
how they affect outcome after surgery, this project was meant to
look at preoperative predictors of mortality, so we did not include
operative complications in the model. Spinal cord ischemia after
TEVAR is an academic interest to our group, and we have lookedhat complication after TEVAR profoundly negatively affects sur-
ival.
Regarding whether we can predict the need for adjunctive
rocedures preoperatively, the answer is yes and no. I think we can
redict the majority of the adjunctive procedures, such as carotid
ubclavian bypass, endo, or open conduits, as well as chimneys
erformed to create proximal and distal landing zones. However,at the effect that it has on mortality. Our rate of spinal cord
ischemia is about 9%, with a permanent deficit in 4%, and having
there were some adjunctive procedures that were performed based
on intraoperative decision making.
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